Report Shares New Details of Death Possibly Linked to Experimental Alzheimer’s Drug | CNN
CNN — The death of a participant in a clinical trial of an antibody treatment for Alzheimer’s disease, which is currently under review by the United States Food and Drug Administration, may be linked to the experimental drug, according to a new report. The research letter, published Wednesday in the New England Journal of Medicine, …